Regulation of ERK2 Dephosphorylation in G1-stimulated Rat T Lymphoblasts

Overview

Journal J Clin Immunol

Publisher Springer

Specialty Allergy & Immunology

Date 1998 Jan 7

PMID 9418190

Authors

C Lisbona

S Alemany

Affiliations

Soon will be listed here.

Abstract

Rat T lymphoblasts arrested in the G1 phase of the cell cycle by interleukin-2 (IL-2) deprivation can be forced to proceed to the S phase when they are stimulated with IL-2 or the phorbol ester phorbol 12,13-dibutyrate (PDBu). When PDBu is used as a stimulus, extracellular regulated kinase 2 (ERK2) is activated by threonine and tyrosine phosphorylation by the dual-specificity kinase MEK. Here we have studied the regulation of ERK2 dephosphorylation as a mechanism for inactivation of this kinase. In vivo inhibition of ERK2 dephosphorylation observed after preincubation with translation or transcription inhibitors (cycloheximide or actinomycin, respectively) indicates the involvement of at least one inducible phosphatase, the best candidate for which is the dual-specificity phosphatase PAC-1. Other noninducible phosphatases must act as well, however, because sodium orthovanadate is a more effective dephosphorylation blocker than cycloheximide. In addition, the okadaic acid effect in ERK2 dephosphorylation indicates that Ser/Thr phosphatases are also involved, directly and/or indirectly.

References

Alessi D, Smythe C, Keyse S . The human CL100 gene encodes a Tyr/Thr-protein phosphatase which potently and specifically inactivates MAP kinase and suppresses its activation by oncogenic ras in Xenopus oocyte extracts. Oncogene. 1993; 8(7):2015-20. View

Taniguchi T . Cytokine signaling through nonreceptor protein tyrosine kinases. Science. 1995; 268(5208):251-5. DOI: 10.1126/science.7716517. View

Coutinho A, Moller G, Anderson J, Bullock W . In vitro activation of mouse lymphocytes in serum-free medium: effect of T and B cell mitogens on proliferation and antibody synthesis. Eur J Immunol. 1973; 3(5):299-306. DOI: 10.1002/eji.1830030509. View

Rohan P, Davis P, Moskaluk C, Kearns M, Krutzsch H, Siebenlist U . PAC-1: a mitogen-induced nuclear protein tyrosine phosphatase. Science. 1993; 259(5102):1763-6. DOI: 10.1126/science.7681221. View

King A, Ozanne B, Smythe C, Ashworth A . Isolation and characterisation of a uniquely regulated threonine, tyrosine phosphatase (TYP 1) which inactivates ERK2 and p54jnk. Oncogene. 1995; 11(12):2553-63. View

Howe L, Weiss A . Multiple kinases mediate T-cell-receptor signaling. Trends Biochem Sci. 1995; 20(2):59-64. DOI: 10.1016/s0968-0004(00)88958-6. View

Blenis J . Signal transduction via the MAP kinases: proceed at your own RSK. Proc Natl Acad Sci U S A. 1993; 90(13):5889-92. PMC: 46831. DOI: 10.1073/pnas.90.13.5889. View

Valge V, Wong J, Datlof B, Sinskey A, Rao A . Protein kinase C is required for responses to T cell receptor ligands but not to interleukin-2 in T cells. Cell. 1988; 55(1):101-12. DOI: 10.1016/0092-8674(88)90013-x. View

Hunter T . Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell. 1995; 80(2):225-36. DOI: 10.1016/0092-8674(95)90405-0. View

10.

Minami Y, Kono T, Miyazaki T, Taniguchi T . The IL-2 receptor complex: its structure, function, and target genes. Annu Rev Immunol. 1993; 11:245-68. DOI: 10.1146/annurev.iy.11.040193.001333. View

11.

Lisbona C, Alemany S, Calvo V . Raf-1 and ERK2 kinases are required for phorbol 12,13-dibutyrate-stimulated proliferation of rat lymphoblasts. ERK2 activation precedes Raf-1 hyperphosphorylation. Eur J Immunol. 1994; 24(11):2746-54. DOI: 10.1002/eji.1830241126. View

12.

Cohen P, Holmes C, Tsukitani Y . Okadaic acid: a new probe for the study of cellular regulation. Trends Biochem Sci. 1990; 15(3):98-102. DOI: 10.1016/0968-0004(90)90192-e. View

13.

Charles C, Abler A, Lau L . cDNA sequence of a growth factor-inducible immediate early gene and characterization of its encoded protein. Oncogene. 1992; 7(1):187-90. View

14.

Siegel J, Klausner R, Rapp U, Samelson L . T cell antigen receptor engagement stimulates c-raf phosphorylation and induces c-raf-associated kinase activity via a protein kinase C-dependent pathway. J Biol Chem. 1990; 265(30):18472-80. View

15.

Orosz C, Roopernian D, Bach F . Phorbol myristate acetate and in vitro T lymphocyte function. I. PMA may contaminate lymphokine preparations and can interfere with interleukin bioassays. J Immunol. 1983; 130(4):1764-9. View

16.

Payne D, Rossomando A, Martino P, Erickson A, Her J, Shabanowitz J . Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase). EMBO J. 1991; 10(4):885-92. PMC: 452730. DOI: 10.1002/j.1460-2075.1991.tb08021.x. View

17.

Gordon J . Use of vanadate as protein-phosphotyrosine phosphatase inhibitor. Methods Enzymol. 1991; 201:477-82. DOI: 10.1016/0076-6879(91)01043-2. View

18.

Freshney N, Rawlinson L, Guesdon F, Jones E, Cowley S, Hsuan J . Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell. 1994; 78(6):1039-49. DOI: 10.1016/0092-8674(94)90278-x. View

19.

Alessi D, Gomez N, Moorhead G, Lewis T, Keyse S, Cohen P . Inactivation of p42 MAP kinase by protein phosphatase 2A and a protein tyrosine phosphatase, but not CL100, in various cell lines. Curr Biol. 1995; 5(3):283-95. DOI: 10.1016/s0960-9822(95)00059-5. View

20.

Ahn N, Weiel J, Chan C, KREBS E . Identification of multiple epidermal growth factor-stimulated protein serine/threonine kinases from Swiss 3T3 cells. J Biol Chem. 1990; 265(20):11487-94. View